19.3 C
Wednesday, July 28, 2021
- Advertisement -



GlaxoSmithKline and CureVac to make Covid vaccines targeting new variants

GlaxoSmithKline has said it will work with a German biopharmaceutical company to develop new vaccines targeting emerging variants of Covid-19 amid concerns that some...

France’s Sanofi to make Covid vaccines from rival Pfizer/BioNTech

French drug maker Sanofi has said it will help manufacture 125 million doses of the coronavirus vaccine developed by its rivals Pfizer and BioNTech,...

GSK throws £130m behind innovative vaccine developer CureVac

British drug giant GlaxoSmithKline has backed a “cutting edge” player in the race to develop a vaccine for coronavirus. GSK said it was putting £130...

Latest news

- Advertisement -